Synthesis of walking sounds for alleviating gait disturbances in Parkinson's disease.

Rodger MW, Young WR, Craig CM.

IEEE Trans Neural Syst Rehabil Eng. 2014 May;22(3):543-8. doi: 10.1109/TNSRE.2013.2285410.

Development of a prediction formula of Parkinson disease severity by optical coherence tomography.

Jiménez B, Ascaso FJ, Cristóbal JA, López del Val J.

Mov Disord. 2014 Jan;29(1):68-74. doi: 10.1002/mds.25747.

Parkinson's disease detection using olfactory loss and REM sleep disorder features.

Prashanth R, Roy SD, Mandal PK, Ghosh S.

Conf Proc IEEE Eng Med Biol Soc. 2014;2014:5764-7. doi: 10.1109/EMBC.2014.6944937.

Nonmotor Symptoms and Cognitive Decline in de novo Parkinson's Disease.

Kwon KY, Kang SH, Kim M, Lee HM, Jang JW, Kim JY, Lee SM, Koh SB.

Can J Neurol Sci. 2014 Sep;41(5):597-602. doi: 10.1017/cjn.2014.3.

Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease.

Kandiah N, Zhang A, Cenina AR, Au WL, Nadkarni N, Tan LC.

Parkinsonism Relat Disord. 2014 Nov;20(11):1145-8. doi: 10.1016/j.parkreldis.2014.08.002.

Sex differences in Parkinson's disease.

Lubomski M, Louise Rushworth R, Lee W, Bertram KL, Williams DR.

J Clin Neurosci. 2014 Sep;21(9):1503-6. doi: 10.1016/j.jocn.2013.12.016.

Mechanisms of body weight fluctuations in Parkinson's disease.

Kistner A, Lhommée E, Krack P.

Front Neurol. 2014 Jun 2;5:84. doi: 10.3389/fneur.2014.00084. Review.

Statistical significance in the selection of the regions of interest for Parkinson brain image processing.

Padilla P, Ramírez J, Górriz JM, Salas-González D, Alvarez-Illán I; Parkinson's Progression Markers Initiative..

Stud Health Technol Inform. 2014;207:19-26.

New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson's disease.

Karasawa H, Pietra C, Giuliano C, Garcia-Rubio S, Xu X, Yakabi S, Taché Y, Wang L.

Neurogastroenterol Motil. 2014 Dec;26(12):1771-82. doi: 10.1111/nmo.12459.

Parkinson disease: Can a new trial end controversy over when to use levodopa?

Rascol O.

Nat Rev Neurol. 2014 Sep;10(9):488-9. doi: 10.1038/nrneurol.2014.147.

Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease.

Parnetti L, Farotti L, Eusebi P, Chiasserini D, De Carlo C, Giannandrea D, Salvadori N, Lisetti V, Tambasco N, Rossi A, Majbour NK, El-Agnaf O, Calabresi P.

Front Aging Neurosci. 2014 Mar 31;6:53. doi: 10.3389/fnagi.2014.00053.

[Key elements for patients and caregivers in the process of living with Parkinson's disease].

Zaragoza Salcedo A, Senosiain García JM, Riverol Fernández M, Anaut Bravo S, Díaz de Cerio Ayesa S, Ursúa Sesma ME, Portillo MC.

An Sist Sanit Navar. 2014 Jan-Apr;37(1):69-80. Spanish.

Positron emission tomography imaging of 5-hydroxytryptamine1B receptors in Parkinson's disease.

Varrone A, Svenningsson P, Forsberg A, Varnäs K, Tiger M, Nakao R, Halldin C, Nilsson LG, Farde L.

Neurobiol Aging. 2014 Apr;35(4):867-75. doi: 10.1016/j.neurobiolaging.2013.08.025.

Relation of clinical subtypes in Parkinson's disease with survival.

de Lau LM, Verbaan D, van Rooden SM, Marinus J, van Hilten JJ.

Mov Disord. 2014 Jan;29(1):150-1. doi: 10.1002/mds.25652. No abstract available.

Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.

Noh SW, Han YH, Mun CW, Chung EJ, Kim EG, Ji KH, Seo JH, Kim SJ.

J Neurol Sci. 2014 Dec 15;347(1-2):210-3. doi: 10.1016/j.jns.2014.09.049.